Hutom Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 68

Employees

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $15M

  • Investors
  • 19

Hutom General Information

Description

Operator of a surgical data platform intended to improve diagnosis through digital innovation. The company's platform specializes in robotics and laparoscopic surgery, analytical diagnosis, and simulated examination of the surgery, and provides 3D anatomical images and AI-based surgical analysis reports, enabling medical professionals to manage patient complications more efficiently.

Contact Information

Website
hutom.io
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 6th Floor, 279, Dongmak-ro
  • Mapo-gu
  • Seoul, 04151
  • South Korea
+82
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 6th Floor, 279, Dongmak-ro
  • Mapo-gu
  • Seoul, 04151
  • South Korea
+82

Hutom Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hutom Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC (Series C) 06-Mar-2024 $15M Completed Generating Revenue
8. Accelerator/Incubator 01-Jan-2023 Completed Generating Revenue
7. Later Stage VC Cancelled Generating Revenue
6. Later Stage VC (Series B) 19-Jan-2022 Completed Generating Revenue
5. Early Stage VC (Series B) 01-Dec-2021 Completed Generating Revenue
4. Early Stage VC (Series A) 01-Jun-2021 Completed Generating Revenue
3. Early Stage VC (Series A) 01-Apr-2018 Completed Generating Revenue
2. Accelerator/Incubator 30-Sep-2017 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Hutom’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Hutom Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a surgical data platform intended to improve diagnosis through digital innovation. The company's platform sp
Decision/Risk Analysis
Seoul, South Korea
68 As of 2026

Palo Alto, CA
 

Strasbourg, France
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Hutom Competitors (3)

One of Hutom’s 3 competitors is Theator, a Venture Capital-Backed company based in Palo Alto, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Theator Venture Capital-Backed Palo Alto, CA
Visible Patient Lab Formerly VC-backed Strasbourg, France
C-SATS Formerly VC-backed Seattle, WA
You’re viewing 3 of 3 competitors. Get the full list »

Hutom Patents

Hutom Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023234492-A1 Method, device, and program for providing patient-specific 3d surgical simulation Inactive 30-May-2022
WO-2023136695-A1 Apparatus and method for generating virtual lung model of patient Inactive 17-Jan-2022
WO-2023136616-A1 Apparatus and method for providing virtual reality-based surgical environment for each surgical situation Inactive 12-Jan-2022
EP-4379740-A1 Device and method for generating virtual pneumoperitoneum model of patient Active 10-Aug-2021
EP-4379740-A4 Device and method for generating virtual pneumoperitoneum model of patient Active 10-Aug-2021 G16H50/50
To view Hutom’s complete patent history, request access »

Hutom Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hutom Investors (19)

Investor Name Investor Type Holding Investor Since Participating Rounds
AJU IB Investment Venture Capital Minority
Bogwang Venture Investment Venture Capital Minority
Bokwang Investment Venture Capital Minority
BYB Investment PE/Buyout Minority
Envester Venture Capital Minority
You’re viewing 5 of 19 investors. Get the full list »

Hutom FAQs

  • When was Hutom founded?

    Hutom was founded in 2017.

  • Where is Hutom headquartered?

    Hutom is headquartered in Seoul, South Korea.

  • What is the size of Hutom?

    Hutom has 68 total employees.

  • What industry is Hutom in?

    Hutom’s primary industry is Decision/Risk Analysis.

  • Is Hutom a private or public company?

    Hutom is a Private company.

  • What is the current valuation of Hutom?

    The current valuation of Hutom is .

  • What is Hutom’s current revenue?

    The current revenue for Hutom is .

  • How much funding has Hutom raised over time?

    Hutom has raised $29.4M.

  • Who are Hutom’s investors?

    AJU IB Investment, Bogwang Venture Investment, Bokwang Investment, BYB Investment, and Envester are 5 of 19 investors who have invested in Hutom.

  • Who are Hutom’s competitors?

    Theator, Visible Patient Lab, and C-SATS are competitors of Hutom.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process